Karafin M - Search Results

1

Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding.

Epperla N, Kapke JT, Karafin M, Friedman KD, Foy P. Epperla N, et al. Among authors: karafin m. Am J Hematol. 2016 Jun;91(6):E313-4. doi: 10.1002/ajh.24367. Epub 2016 Apr 28. Am J Hematol. 2016. PMID: 26994402 Free article. No abstract available.

2

Differentiation of pernicious anemia from thrombotic thrombocytopenic purpura: The clinical value of subtle pathologic findings.

Abbott DW, Friedman KD, Karafin MS. Abbott DW, et al. Transfus Apher Sci. 2016 Dec;55(3):318-322. doi: 10.1016/j.transci.2016.08.005. Epub 2016 Sep 28. Transfus Apher Sci. 2016. PMID: 27765664

3

Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?

Epperla N, Kleman A, Karafin M, Foy P. Epperla N, et al. Among authors: karafin m. Ann Hematol. 2018 Sep;97(9):1727-1729. doi: 10.1007/s00277-018-3324-7. Epub 2018 Apr 14. Ann Hematol. 2018. PMID: 29656313 No abstract available.

4

Intensive management of high-utilizing adults with sickle cell disease lowers admissions.

Koch KL, Karafin MS, Simpson P, Field JJ. Koch KL, et al. Am J Hematol. 2015 Mar;90(3):215-9. doi: 10.1002/ajh.23912. Epub 2015 Jan 16. Am J Hematol. 2015. PMID: 25469750 Free article.

5

A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.

Karafin MS, Singavi A, Johnson ST, Field JJ. Karafin MS, et al. Hematol Rep. 2017 Mar 1;9(1):6934. doi: 10.4081/hr.2017.6934. eCollection 2017 Feb 23. Hematol Rep. 2017. PMID: 28286630 Free PMC article.

6

Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease.

Karafin MS, Singh M, Ceesay M, Koduri S, Zhang L, Simpson P, Field JJ. Karafin MS, et al. Hematology. 2018 Sep;23(8):531-536. doi: 10.1080/10245332.2018.1430521. Epub 2018 Jan 29. Hematology. 2018. PMID: 29376481 Free article. Clinical Trial.

7

Predictive factors of daily opioid use and quality of life in adults with sickle cell disease.

Karafin MS, Singavi A, Hussain J, Wandersee N, Heinrich T, Hurley RW, Zhang L, Simpson P, Field JJ. Karafin MS, et al. Hematology. 2018 Dec;23(10):856-863. doi: 10.1080/10245332.2018.1479997. Epub 2018 May 31. Hematology. 2018. PMID: 29848208 Free article. Clinical Trial.

8

The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.

Karafin MS, Fu X, D'Alessandro A, Thomas T, Hod EA, Zimring JC, Field JJ, Francis RO. Karafin MS, et al. Curr Opin Hematol. 2018 Nov;25(6):494-499. doi: 10.1097/MOH.0000000000000455. Curr Opin Hematol. 2018. PMID: 30239377 Review.

9

Mechanisms of alloimmunization in sickle cell disease.

Hudson KE, Fasano RM, Karafin MS, Hendrickson JE, Francis RO. Hudson KE, et al. Among authors: karafin ms. Curr Opin Hematol. 2019 Nov;26(6):434-441. doi: 10.1097/MOH.0000000000000540. Curr Opin Hematol. 2019. PMID: 31483335 Review.

10

The controversial role of red cell transfusions for sickle cell pain.

Karafin MS, Field JJ. Karafin MS, et al. Curr Opin Hematol. 2019 Nov;26(6):442-447. doi: 10.1097/MOH.0000000000000537. Curr Opin Hematol. 2019. PMID: 31567433 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters